Concepedia
Statistics
Publications
4
Citations
796
H-Index
Active since
2013
Affiliations
Janssen (United States)(Current)
University of California San Diego
Profil Institute for Metabolic Research
Kristin Farrell is an author at Janssen (United States) specializing in diabetes management, pharmacology, and diabetes mellitus.
Publications per year
2013–2018
Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion
David Polidori, Sue Sha, Sunder Mudaliar et al. · Diabetes Care · 2013 · 263 citations · Full text
Medicine, Endocrinology, Pharmacology +17
Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus
Sue Sha, David Polidori, Tim Heise et al. · Diabetes Obesity and Metabolism · 2014 · 244 citations
Medicine, Pharmacology, Pharmacotherapy +17
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
Kenneth Cusi, Fernando Bril, Diana Barb et al. · Diabetes Obesity and Metabolism · 2018 · 197 citations
Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double‐blind, crossover study
Sue Sha, David Polidori, Kristin Farrell et al. · Diabetes Obesity and Metabolism · 2014 · 92 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
1–4 of 4